Edward J. Natoli

1.3k total citations
13 papers, 1.0k citations indexed

About

Edward J. Natoli is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Edward J. Natoli has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Edward J. Natoli's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Immunotherapy and Immune Responses (3 papers). Edward J. Natoli is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Immunotherapy and Immune Responses (3 papers). Edward J. Natoli collaborates with scholars based in United States. Edward J. Natoli's co-authors include Saralyn Lindsey, Weifan Weng, Patricia-Ann K. Bourassa, Robert J. Aiello, Barrett J. Rollins, Patrice M. Milos, Lloyd J. Old, M J Calves, P O Livingston and Herbert F. Oettgen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Edward J. Natoli

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward J. Natoli United States	12	579	488	307	241	112	13	1.0k
Birgit Bossenmaier Germany	19	281 0.5×	807 1.7×	816 2.7×	659 2.7×	114 1.0×	42	1.8k
Wim H.A. Dokter Netherlands	19	252 0.4×	471 1.0×	572 1.9×	364 1.5×	93 0.8×	44	1.3k
Carol Prokop United States	8	656 1.1×	438 0.9×	240 0.8×	43 0.2×	47 0.4×	9	1.1k
Penglie Zhang United States	18	586 1.0×	350 0.7×	583 1.9×	53 0.2×	60 0.5×	37	1.2k
S. Virudachalam United States	11	143 0.2×	640 1.3×	356 1.2×	202 0.8×	31 0.3×	17	987
Gengyun Wen United States	10	364 0.6×	890 1.8×	272 0.9×	136 0.6×	35 0.3×	10	1.1k
Jean‐Philip Truman United States	19	299 0.5×	677 1.4×	187 0.6×	115 0.5×	112 1.0×	28	1.2k
Mariko Muta Japan	16	568 1.0×	600 1.2×	726 2.4×	109 0.5×	50 0.4×	24	1.4k
Frédérique Deshayes France	19	329 0.6×	545 1.1×	241 0.8×	51 0.2×	32 0.3×	31	1.2k

Countries citing papers authored by Edward J. Natoli

Since Specialization

Citations

This map shows the geographic impact of Edward J. Natoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Natoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Natoli more than expected).

Fields of papers citing papers by Edward J. Natoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Natoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Natoli. The network helps show where Edward J. Natoli may publish in the future.

Co-authorship network of co-authors of Edward J. Natoli

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Natoli. A scholar is included among the top collaborators of Edward J. Natoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Natoli. Edward J. Natoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Murray, Phillip B., Irit Lax, Andrey V. Reshetnyak, et al.. (2015). Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK. Science Signaling. 8(360). ra6–ra6. 66 indexed citations

Lee, Sangwon, Joseph Amick, Gwenda F. Ligon, et al.. (2015). Inhibition of ErbB3 by a monoclonal antibody that locks the extracellular domain in an inactive configuration. Proceedings of the National Academy of Sciences. 112(43). 13225–13230. 30 indexed citations

Hynes, James T., Edward J. Natoli, & Yvonne Will. (2009). Fluorescent pH and Oxygen Probes of the Assessment of Mitochondrial Toxicity in Isolated Mitochondria and Whole Cells. Current Protocols in Toxicology. 40(1). Unit 2.16–Unit 2.16. 20 indexed citations

Bedian, Vahe, Carol Donovan, Joseph P. Gardner, et al.. (2006). In vitro characterization and pre-clinical pharmacokinetics of CP-870,893, a human anti-CD40 agonist antibody. Journal of Clinical Oncology. 24(18_suppl). 2539–2539. 8 indexed citations

Gladue, Ronald P., et al.. (2006). In vivo efficacy of the CD40 agonist antibody CP-870,893 against a broad range of tumor types: Impact of tumor CD40 expression, dendritic cells, and chemotherapy. Journal of Clinical Oncology. 24(18_suppl). 2514–2514. 11 indexed citations

Hanson, Douglas C., Paul C. Canniff, Michael J. Primiano, et al.. (2004). Preclinical in vitro characterization of anti-CTLA4 therapeutic antibody CP-675,206.. Cancer Research. 64. 877–877. 30 indexed citations

Aiello, Robert J., Patricia-Ann K. Bourassa, Saralyn Lindsey, et al.. (1999). Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 19(6). 1518–1525. 388 indexed citations

Otterness, Ivan G., Marcia L. Bliven, James T. Downs, Edward J. Natoli, & Douglas C. Hanson. (1991). Inhibition of interleukin 1 synthesis by tenidap: A new drug for arthritis. Cytokine. 3(4). 277–283. 42 indexed citations

Grissmer, Stephan, Douglas C. Hanson, Edward J. Natoli, Michael D. Cahalan, & K. George Chandy. (1990). CD4-CD8- T cells from mice with collagen arthritis display aberrant expression of type l K+ channels.. The Journal of Immunology. 145(7). 2105–2109. 13 indexed citations

10.

Welte, Karl, Glenn T. Miller, Paul B. Chapman, et al.. (1987). Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside.. The Journal of Immunology. 139(6). 1763–1771. 101 indexed citations

11.

Livingston, P O, M J Calves, & Edward J. Natoli. (1987). Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.. The Journal of Immunology. 138(5). 1524–1529. 54 indexed citations

12.

Livingston, P O, Edward J. Natoli, M J Calves, et al.. (1987). Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.. Proceedings of the National Academy of Sciences. 84(9). 2911–2915. 189 indexed citations

13.

Natoli, Edward J., Philip O. Livingston, Clifford Pukel, et al.. (1986). A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity.. PubMed. 46(8). 4116–20. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact